Yining Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yining Wang has a total of 779 co-authors. Here are the top co-authors by number of shared publications:
Xiao Li
Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
24 shared publicationsCheng Xu
19 shared publications- Zhengyu Jin
Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
19 shared publications Lu Lin
Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
18 shared publications- Tao Jiang
The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China
18 shared publications Yi Zhou
The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University, Wuhan, China
16 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in NeuroImage
- Vol. 342, 122276
Characterizing age-dependent diamagnetic and paramagnetic susceptibility properties in 5xFAD Alzheimer’s mouse brain using high-resolution MRI
- 15 October 2026
- Published by Elsevier in NeuroImage
- Vol. 342, 122276
Open AccessCharacterizing age-dependent diamagnetic and paramagnetic susceptibility properties in 5xFAD Alzheimer’s mouse brain using high-resolution MRI
- Open Access
- 12 October 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (9) , ztag163
AI-powered optical coherence tomography shows similar performance to intravascular ultrasound for plaque burden quantification: head-to-head benchmark study against histopathology of native coronary arteries
Aims: Optical coherence tomography (OCT) provides excellent resolution at the cost of shallow penetration, limiting its ability for plaque burden (PB) assessment. A deep learning (DL) algorithm was therefore developed to provide fully automated assessment of PB and vessel size from OCT. We aimed to perform a head-to-head comparison of AI-powered OCT vs. intravascular ultrasound (IVUS) for PB quantification, using histopathology as the reference standard. Methods and results: Ten post-mortem human hearts were harvested. All 29 major epicardial coronary arteries were perfused and underwent OCT and IVUS pullbacks. After imaging, the arteries were serially sectioned at 1-mm intervals for histopathology. Lumen and vessel contours were derived fully automatically from OCT using the DL algorithm and semi-automatically from IVUS. Histopathological measurements were obtained by experienced analysts. Statistical analyses accounted for within-patient clustering. A total of 852 paired OCT-IVUS histopathology cross-sections were obtained. AI-powered OCT showed strong correlations with histopathology for the assessment of lumen area (r = 0.89 [95% CI: 0.88–0.91]), vessel area (r = 0.85 [95% CI: 0.83–0.87]), and PB (r = 0.76 [95% CI: 0.73–0.79]). The corresponding correlations between IVUS and histopathology were 0.90 (95% CI: 0.89–0.92), 0.86 (95% CI: 0.84–0.88), and 0.79 (95% CI: 0.76–0.81), respectively. Comparisons of the OCT–histopathology and IVUS–histopathology correlation coefficients yielded P = 0.336 for lumen area, P = 0.444 for vessel area, and P = 0.161 for PB. Both OCT and IVUS showed good diagnostic performance in identifying PB > 65%, with the area under the receiver operating characteristic curve being 0.92 (95% CI: 0.90–0.94) and 0.92 (95% CI: 0.88–0.95), respectively. Conclusion: In this histopathology validation study of 10 post-mortem human hearts, AI-powered OCT enabled fully automated plaque burden quantification and correlated strongly with histopathology, with no statistically significant difference between the OCT–histopathology and IVUS–histopathology correlations.
- 12 October 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Digital Health
- Vol. 7 (9) , ztag163
Open AccessAI-powered optical coherence tomography shows similar performance to intravascular ultrasound for plaque burden quantification: head-to-head benchmark study against histopathology of native coronary arteries
Aims: Optical coherence tomography (OCT) provides excellent resolution at the cost of shallow penetration, limiting its ability for plaque burden (PB) assessment. A deep learning (DL) algorithm was therefore developed to provide fully automated assessment of PB and vessel size from OCT. We aimed to perform a head-to-head comparison of AI-powered OCT vs. intravascular ultrasound (IVUS) for PB quantification, using histopathology as the reference standard. Methods and results: Ten post-mortem human hearts were harvested. All 29 major epicardial coronary arteries were perfused and underwent OCT and IVUS pullbacks. After imaging, the arteries were serially sectioned at 1-mm intervals for histopathology. Lumen and vessel contours were derived fully automatically from OCT using the DL algorithm and semi-automatically from IVUS. Histopathological measurements were obtained by experienced analysts. Statistical analyses accounted for within-patient clustering. A total of 852 paired OCT-IVUS histopathology cross-sections were obtained. AI-powered OCT showed strong correlations with histopathology for the assessment of lumen area (r = 0.89 [95% CI: 0.88–0.91]), vessel area (r = 0.85 [95% CI: 0.83–0.87]), and PB (r = 0.76 [95% CI: 0.73–0.79]). The corresponding correlations between IVUS and histopathology were 0.90 (95% CI: 0.89–0.92), 0.86 (95% CI: 0.84–0.88), and 0.79 (95% CI: 0.76–0.81), respectively. Comparisons of the OCT–histopathology and IVUS–histopathology correlation coefficients yielded P = 0.336 for lumen area, P = 0.444 for vessel area, and P = 0.161 for PB. Both OCT and IVUS showed good diagnostic performance in identifying PB > 65%, with the area under the receiver operating characteristic curve being 0.92 (95% CI: 0.90–0.94) and 0.92 (95% CI: 0.88–0.95), respectively. Conclusion: In this histopathology validation study of 10 post-mortem human hearts, AI-powered OCT enabled fully automated plaque burden quantification and correlated strongly with histopathology, with no statistically significant difference between the OCT–histopathology and IVUS–histopathology correlations.
- Open Access
- 1 October 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (10) , 802
Quantification of plaque and detection of high-risk plaque characteristics based on coronary computed tomography angiography: comparison between superresolution deep learning reconstruction and hybrid iterative reconstruction
Background: In addition to stenosis evaluation, coronary computed tomography angiography (CCTA) also allows for noninvasive plaque quantification and characterization, which informs risk stratification and management strategies. This study aimed to compare a novel superresolution deep learning reconstruction (SR-DLR) technique with a conventional hybrid iterative reconstruction (HIR) method in quantifying CCTA-derived plaque and detecting high-risk plaque (HRP) characteristics. Methods: A total of 255 consecutive patients (mean age 63.7±9.6 years; 184 men and 71 women) who underwent clinically indicated CCTA for assessment of suspected or known coronary artery disease were prospectively enrolled. The HIR algorithm with the FC43 kernel and the SR-DLR algorithm with the cardiac kernel reconstructed the same raw CCTA data. Total plaque, calcified plaque, noncalcified plaque (NCP), and low-attenuation plaque (LAP) volumes were quantified. Moreover, the ability to detect HRP characteristics (LAP, spotty calcification, positive remodeling, and napkin-ring sign) was evaluated. Paired comparisons were made between the two reconstruction pipelines. Results: Compared with the HIR pipeline, the SR-DLR pipeline obtained higher median volumes of total plaque {103.4 [interquartile range (IQR) 52.9–201.7] vs. 124.5 (IQR 66.8–236.2) mm3}, NCP [43.9 (IQR 20.1–87.7) vs. 56.4 (IQR 25.2–115.7) mm3], and LAP [0.1 (IQR 0–3.0) vs. 0.9 (IQR 0–8.7) mm3] (all P0.99), or napkin-ring sign (42 vs. 40, P=0.76). Conclusions: Compared with the HIR pipeline, the SR-DLR pipeline indicated higher total plaque, NCP, and LAP volumes, but no difference in calcified plaque volume was observed. Moreover, SR-DLR detected more LAPs than did HIR, while other HRP characteristics did not differ significantly. Further large-scale prospective studies including a reference standard are warranted to investigate the clinical impact of SR-DLR.
- 1 October 2026
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 16 (10) , 802
Open AccessQuantification of plaque and detection of high-risk plaque characteristics based on coronary computed tomography angiography: comparison between superresolution deep learning reconstruction and hybrid iterative reconstruction
Background: In addition to stenosis evaluation, coronary computed tomography angiography (CCTA) also allows for noninvasive plaque quantification and characterization, which informs risk stratification and management strategies. This study aimed to compare a novel superresolution deep learning reconstruction (SR-DLR) technique with a conventional hybrid iterative reconstruction (HIR) method in quantifying CCTA-derived plaque and detecting high-risk plaque (HRP) characteristics. Methods: A total of 255 consecutive patients (mean age 63.7±9.6 years; 184 men and 71 women) who underwent clinically indicated CCTA for assessment of suspected or known coronary artery disease were prospectively enrolled. The HIR algorithm with the FC43 kernel and the SR-DLR algorithm with the cardiac kernel reconstructed the same raw CCTA data. Total plaque, calcified plaque, noncalcified plaque (NCP), and low-attenuation plaque (LAP) volumes were quantified. Moreover, the ability to detect HRP characteristics (LAP, spotty calcification, positive remodeling, and napkin-ring sign) was evaluated. Paired comparisons were made between the two reconstruction pipelines. Results: Compared with the HIR pipeline, the SR-DLR pipeline obtained higher median volumes of total plaque {103.4 [interquartile range (IQR) 52.9–201.7] vs. 124.5 (IQR 66.8–236.2) mm3}, NCP [43.9 (IQR 20.1–87.7) vs. 56.4 (IQR 25.2–115.7) mm3], and LAP [0.1 (IQR 0–3.0) vs. 0.9 (IQR 0–8.7) mm3] (all P0.99), or napkin-ring sign (42 vs. 40, P=0.76). Conclusions: Compared with the HIR pipeline, the SR-DLR pipeline indicated higher total plaque, NCP, and LAP volumes, but no difference in calcified plaque volume was observed. Moreover, SR-DLR detected more LAPs than did HIR, while other HRP characteristics did not differ significantly. Further large-scale prospective studies including a reference standard are warranted to investigate the clinical impact of SR-DLR.
- Open Access
- 22 September 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
Computed tomography angiography findings and clinical characteristics of aneurysms in patients with Behçet’s disease: a retrospective study
Objectives: To retrospectively evaluate computed tomography angiography (CTA) findings and associated clinical features of aneurysms in patients with Behçet’s disease (BD), with the aim of informing optimal management strategies. Methods: We reviewed BD patients with aneurysms admitted to our institution between 1997 and 2020. All patients underwent pre-treatment CTA. Radiographic features and clinical data were analyzed, with follow-up CTA used to assess outcomes. Results: Fifty-six patients (median age of 48 years; 82.1% male) were included. BD was diagnosed at a median age of 33 years, with a median interval of 6 years to aneurysm onset. A total of 67 aneurysms were identified: 36 true aneurysms, 29 pseudo-aneurysms, and 2 dissecting aneurysms, most commonly involving the abdominal aorta, popliteal, and iliac arteries. Concurrent thrombosis occurred in 7 patients, affecting lower extremity deep veins, the inferior vena cava, or cerebral venous sinuses. Interventions were performed in 60.7% (34/56), including endovascular stent placement. Among 34 patients with follow-up CTA, 88% showed complete aneurysm resolution. Conclusions: Vascular complications are frequent and life-threatening in BD. CTA reliably identifies aneurysm type and coexisting thrombosis, supports preoperative planning through anatomical and hemodynamics assessment, and enables accurate monitoring of treatment efficacy and recurrence. Advances in knowledge: This study provides one of the largest single-center series describing CTA findings in BD-related aneurysms, and highlights the clinical utility of CTA for lesion characterization and longitudinal assessment in this high-risk population.
- 22 September 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
Open AccessComputed tomography angiography findings and clinical characteristics of aneurysms in patients with Behçet’s disease: a retrospective study
Objectives: To retrospectively evaluate computed tomography angiography (CTA) findings and associated clinical features of aneurysms in patients with Behçet’s disease (BD), with the aim of informing optimal management strategies. Methods: We reviewed BD patients with aneurysms admitted to our institution between 1997 and 2020. All patients underwent pre-treatment CTA. Radiographic features and clinical data were analyzed, with follow-up CTA used to assess outcomes. Results: Fifty-six patients (median age of 48 years; 82.1% male) were included. BD was diagnosed at a median age of 33 years, with a median interval of 6 years to aneurysm onset. A total of 67 aneurysms were identified: 36 true aneurysms, 29 pseudo-aneurysms, and 2 dissecting aneurysms, most commonly involving the abdominal aorta, popliteal, and iliac arteries. Concurrent thrombosis occurred in 7 patients, affecting lower extremity deep veins, the inferior vena cava, or cerebral venous sinuses. Interventions were performed in 60.7% (34/56), including endovascular stent placement. Among 34 patients with follow-up CTA, 88% showed complete aneurysm resolution. Conclusions: Vascular complications are frequent and life-threatening in BD. CTA reliably identifies aneurysm type and coexisting thrombosis, supports preoperative planning through anatomical and hemodynamics assessment, and enables accurate monitoring of treatment efficacy and recurrence. Advances in knowledge: This study provides one of the largest single-center series describing CTA findings in BD-related aneurysms, and highlights the clinical utility of CTA for lesion characterization and longitudinal assessment in this high-risk population.
- Open Access
- 1 September 2026
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (10) , e70383
Quantifying the Diamagnetic and Paramagnetic Components of Beta‐Amyloid Plaques Using Decomposed Quantitative Susceptibility Mapping in Mouse Models of Alzheimer's Disease
High‐resolution quantitative susceptibility mapping (QSM) combined with susceptibility source decomposition provides a powerful approach for investigating the magnetic susceptibility alterations in Alzheimer's disease (AD). In this study, ex vivo three‐dimensional multi‐echo gradient‐echo (mGRE) images of 5xFAD and mouse brains were acquired at 30 isotropic resolution using a 9.4 T MRI scanner. QSM was reconstructed and decomposed into diamagnetic component susceptibility (DCS) and paramagnetic component susceptibility (PCS). Individual amyloid‐beta () plaques were automatically detected and their susceptibility properties were quantitatively characterized. DCS and PCS revealed subvoxel mixtures of diamagnetic and paramagnetic components. Compared with conventional QSM, DCS exhibited clearer plaque visualization and higher plaque detection sensitivity. Histological analysis revealed the coexistence of aggregates and ferritin in both mouse models, with most plaques measuring less than 70 in diameter. To assess the impact of spatial resolution on plaque visualization and susceptibility quantification, the acquired k‐space data were downsampled to isotropic resolutions of 45, 60, and 90 m. As spatial resolution became coarser, plaque visibility degraded progressively, resulting in reductions in both the number of detectable plaques and the estimated plaque burden. Whole‐cortex plaque loading decreased from 8.9% at 30 m to 3.1% at 90 m in 5xFAD and from 6.5% to 2.6% in mice. In both models, detected plaques exhibited predominantly diamagnetic susceptibility, with the diamagnetic component accounting for approximately 80% of the total absolute susceptibility. These findings demonstrate that high‐resolution susceptibility mapping combined with source decomposition enables plaque‐level characterization of diamagnetic and paramagnetic contributions and provides complementary biomarkers for assessing pathology and associated iron dysregulation in preclinical mouse models of AD.
- 1 September 2026
- Published by Wiley in NMR in Biomedicine
- Vol. 39 (10) , e70383
Open AccessQuantifying the Diamagnetic and Paramagnetic Components of Beta‐Amyloid Plaques Using Decomposed Quantitative Susceptibility Mapping in Mouse Models of Alzheimer's Disease
High‐resolution quantitative susceptibility mapping (QSM) combined with susceptibility source decomposition provides a powerful approach for investigating the magnetic susceptibility alterations in Alzheimer's disease (AD). In this study, ex vivo three‐dimensional multi‐echo gradient‐echo (mGRE) images of 5xFAD and mouse brains were acquired at 30 isotropic resolution using a 9.4 T MRI scanner. QSM was reconstructed and decomposed into diamagnetic component susceptibility (DCS) and paramagnetic component susceptibility (PCS). Individual amyloid‐beta () plaques were automatically detected and their susceptibility properties were quantitatively characterized. DCS and PCS revealed subvoxel mixtures of diamagnetic and paramagnetic components. Compared with conventional QSM, DCS exhibited clearer plaque visualization and higher plaque detection sensitivity. Histological analysis revealed the coexistence of aggregates and ferritin in both mouse models, with most plaques measuring less than 70 in diameter. To assess the impact of spatial resolution on plaque visualization and susceptibility quantification, the acquired k‐space data were downsampled to isotropic resolutions of 45, 60, and 90 m. As spatial resolution became coarser, plaque visibility degraded progressively, resulting in reductions in both the number of detectable plaques and the estimated plaque burden. Whole‐cortex plaque loading decreased from 8.9% at 30 m to 3.1% at 90 m in 5xFAD and from 6.5% to 2.6% in mice. In both models, detected plaques exhibited predominantly diamagnetic susceptibility, with the diamagnetic component accounting for approximately 80% of the total absolute susceptibility. These findings demonstrate that high‐resolution susceptibility mapping combined with source decomposition enables plaque‐level characterization of diamagnetic and paramagnetic contributions and provides complementary biomarkers for assessing pathology and associated iron dysregulation in preclinical mouse models of AD.
- Open Access
- 6 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5262
Cardiac Involvement in Cryoglobulinemia: Clinical Characteristics, Radiological Features, and Outcomes
Background: Cardiac involvement in cryoglobulinemia (CG) is rare but potentially fatal, and its clinical spectrum remains poorly characterized. Methods: This retrospective study enrolled 11 patients with cardiac involvement among 885 patients with CG at Peking Union Medical College Hospital between January 2015 and March 2026. We analyzed its clinical characteristics, radiological features and management. Results: Among 885 CG patients, 11 (1.2%; 4 type I, 7 type II) had cardiac involvement. Cardiac symptoms included dyspnea (n = 6), chest tightness (n = 4), edema (n = 3), and orthopnea (n = 1). All patients had elevated N-terminal pro-B-type natriuretic peptide (median 29,799 pg/mL). Echocardiography, performed in all 11 patients, revealed left heart enlargement (n = 9), reduced left ventricular ejection fraction (n = 7), myocardial disease (n = 6), pericardial effusion (n = 4), and pulmonary hypertension (n = 3). Cardiac magnetic resonance in 5 of 11 patients showed non-ischemic late gadolinium enhancement in two cases. For first-line therapy, 6 of 11 patients received rituximab-based regimens, 3 of 11 received bortezomib-based regimens, and 1 of 11 received antiviral therapy with corticosteroids; 1 patient declined treatment. All 10 treated patients achieved initial cardiac improvement, with 5 relapsing and 2 dying during a median follow-up of 57 months (range 9–130 months). The estimated 4-year overall and progression-free survival rates were 77.9% (95% CI: 0.546–1.000) and 50.0% (95% CI: 0.269–0.929), respectively. Conclusions: Cardiac involvement in CG is rare and associated with diverse structural and functional abnormalities. Cardiac involvement should be considered in CG patients presenting with unexplained cardiac manifestations after excluding alternative causes. B-cell-targeted therapy induced an initial response, but relapse is common. Early intervention is essential given the substantial relapse burden and potential for severe morbidity.
- 6 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5262
Open AccessCardiac Involvement in Cryoglobulinemia: Clinical Characteristics, Radiological Features, and Outcomes
Background: Cardiac involvement in cryoglobulinemia (CG) is rare but potentially fatal, and its clinical spectrum remains poorly characterized. Methods: This retrospective study enrolled 11 patients with cardiac involvement among 885 patients with CG at Peking Union Medical College Hospital between January 2015 and March 2026. We analyzed its clinical characteristics, radiological features and management. Results: Among 885 CG patients, 11 (1.2%; 4 type I, 7 type II) had cardiac involvement. Cardiac symptoms included dyspnea (n = 6), chest tightness (n = 4), edema (n = 3), and orthopnea (n = 1). All patients had elevated N-terminal pro-B-type natriuretic peptide (median 29,799 pg/mL). Echocardiography, performed in all 11 patients, revealed left heart enlargement (n = 9), reduced left ventricular ejection fraction (n = 7), myocardial disease (n = 6), pericardial effusion (n = 4), and pulmonary hypertension (n = 3). Cardiac magnetic resonance in 5 of 11 patients showed non-ischemic late gadolinium enhancement in two cases. For first-line therapy, 6 of 11 patients received rituximab-based regimens, 3 of 11 received bortezomib-based regimens, and 1 of 11 received antiviral therapy with corticosteroids; 1 patient declined treatment. All 10 treated patients achieved initial cardiac improvement, with 5 relapsing and 2 dying during a median follow-up of 57 months (range 9–130 months). The estimated 4-year overall and progression-free survival rates were 77.9% (95% CI: 0.546–1.000) and 50.0% (95% CI: 0.269–0.929), respectively. Conclusions: Cardiac involvement in CG is rare and associated with diverse structural and functional abnormalities. Cardiac involvement should be considered in CG patients presenting with unexplained cardiac manifestations after excluding alternative causes. B-cell-targeted therapy induced an initial response, but relapse is common. Early intervention is essential given the substantial relapse burden and potential for severe morbidity.
- Open Access
- 11 April 2026
- Published by Elsevier in NeuroImage
- Vol. 332, 121922
Detecting early brain susceptibility changes before demyelination in cuprizone mouse model using quantitative susceptibility mapping (QSM)
- 11 April 2026
- Published by Elsevier in NeuroImage
- Vol. 332, 121922
Open AccessDetecting early brain susceptibility changes before demyelination in cuprizone mouse model using quantitative susceptibility mapping (QSM)
- 14 February 2026
- Published by Elsevier in Journal of Controlled Release
- Vol. 392, 114729
Nucleic acid drug delivery in ophthalmology: Emerging trends and future perspectives
- 14 February 2026
- Published by Elsevier in Journal of Controlled Release
- Vol. 392, 114729
Nucleic acid drug delivery in ophthalmology: Emerging trends and future perspectives
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (2) , e252163
Super-Resolution Deep Learning Reconstruction for Coronary CT Angiography: Coronary Stenosis Assessment and CAD-RADS Reclassification
Super-resolution deep learning reconstruction for coronary CT angiography outperformed hybrid iterative reconstruction for assessing coronary stenosis, resulting in a 20% participant-level reclassification of Coronary Artery Disease Reporting and Data System category.
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (2) , e252163
Super-Resolution Deep Learning Reconstruction for Coronary CT Angiography: Coronary Stenosis Assessment and CAD-RADS Reclassification
Super-resolution deep learning reconstruction for coronary CT angiography outperformed hybrid iterative reconstruction for assessing coronary stenosis, resulting in a 20% participant-level reclassification of Coronary Artery Disease Reporting and Data System category.
- 25 January 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1186) , 2032-2034
Coronary computed tomography angiography as a screening tool (invited commentary)
Coronary computed tomography angiography (CCTA) has evolved into a key non-invasive tool for evaluating coronary artery disease, offering high sensitivity, detailed anatomical visualization, and strong prognostic value. Current Society of Cardiovascular Computed Tomography guidelines recommend CCTA as a first-line test for symptomatic patients, while limiting its use in asymptomatic individuals to select high-risk cases. Advantages in a screening context include early detection of subclinical atherosclerosis, prognostic assessment through high-risk plaque features, and facilitation of personalized preventive strategies. However, widespread screening faces challenges: procedural complexity, contrast and radiation exposure, psychological impact, and economic cost. Emerging integration of artificial intelligence promises to enhance efficiency, automate plaque quantification, and enable individualized risk prediction, potentially improving cost-effectiveness and clinical adoption. Future validation through randomized controlled trials and real-world data is needed to confirm the impact of CCTA-based screening on cardiovascular event reduction, healthcare resource use, and patient quality of life.
- 25 January 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99 (1186) , 2032-2034
Coronary computed tomography angiography as a screening tool (invited commentary)
Coronary computed tomography angiography (CCTA) has evolved into a key non-invasive tool for evaluating coronary artery disease, offering high sensitivity, detailed anatomical visualization, and strong prognostic value. Current Society of Cardiovascular Computed Tomography guidelines recommend CCTA as a first-line test for symptomatic patients, while limiting its use in asymptomatic individuals to select high-risk cases. Advantages in a screening context include early detection of subclinical atherosclerosis, prognostic assessment through high-risk plaque features, and facilitation of personalized preventive strategies. However, widespread screening faces challenges: procedural complexity, contrast and radiation exposure, psychological impact, and economic cost. Emerging integration of artificial intelligence promises to enhance efficiency, automate plaque quantification, and enable individualized risk prediction, potentially improving cost-effectiveness and clinical adoption. Future validation through randomized controlled trials and real-world data is needed to confirm the impact of CCTA-based screening on cardiovascular event reduction, healthcare resource use, and patient quality of life.